Start a New Search
SHOWING 14 RESULTS
Findings suggests abnormal blood flow between mothers, babies in utero
Confronting COVID-19 | Northwestern UniversityA team of Northwestern University engineers has found a way to retrofit a common commercial emergency ventilator (Vortran Go2Vent®) into a device better suited for COVID-19 patients.
Confronting COVID-19 | Northwestern UniversityMaterial can withstand damage from disinfection, enabling masks to be safely reused
Confronting COVID-19 | Northwestern UniversityNorthwestern University researchers have developed a new method for testing for SARS-CoV-2 (the virus that causes COVID-19) antibodies. The method requires only a single drop of blood collected from a simple finger prick.
Confronting COVID-19 | Northwestern UniversityNorthwestern University researchers are using artificial intelligence (AI) to speed up the search for COVID-19 treatments and vaccines. The AI-powered tool makes it possible to prioritize resources for the most promising studies — and ignore research that is unlikely to yield benefits.
Confronting COVID-19 | Northwestern UniversityResearchers at Northwestern have developed a novel wearable device to catch early signs and symptoms associated with COVID-19
Confronting COVID-19 | Northwestern UniversityAn interdisciplinary team at Northwestern to assess how public thinks, feels and behaves during global pandemic
Confronting COVID-19 | Northwestern UniversityResearchers are ramping up production of a promising drug that has proven effective in obliterating SARS-CoV in cellular cultures. The team hopes that the drug might also be effective in the fight against SARS’s close genetic cousin, the novel coronavirus.
Confronting COVID-19 | Northwestern UniversityNorthwestern Medicine cardiovascular experts discuss how racial disparities, including lower socioeconomic status and pre-existing cardiovascular conditions, can lead African-Americans to be at higher risk for contracting and dying from COVID-19.
Confronting COVID-19 | Northwestern UniversityResearchers are developing new peptide-based therapeutics for targeting and disabling the coronavirus’ so-called “spike proteins.”
Confronting COVID-19 | Northwestern University